share_log
Moomoo 24/7 ·  Apr 22 07:03
Krystal Biotech Has Dosed The First Patient In Its Phase 1 Clinical Trial (KYANITE-1) Evaluating Inhaled KB707 For Locally Advanced Or Metastatic Solid Tumors Of The Lung
Disclaimer: This content is for informational and educational purposes only and does not constitute a recommendation or endorsement of any specific investment or investment strategy. Read more
    Write a comment